BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.52B |
| 2 |
Visa
V
|
+$442M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$391M |
| 4 |
DuPont de Nemours
DD
|
+$296M |
| 5 |
NVIDIA
NVDA
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$643M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$407M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$245M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$243M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.29% |
| 2 | Consumer Discretionary | 8.84% |
| 3 | Healthcare | 6.65% |
| 4 | Financials | 5.52% |
| 5 | Industrials | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Fidelity D&D Bancorp
FDBC
$321M
| $59.4K | ﹤0.01% |
1,223
+1,214
| +13,489% | +$52.8K |
|
3302
Rigel Pharmaceuticals
RIGL
$762M
| $59.2K | ﹤0.01% |
4,591
-2,334
| -34% | -$31.6K |
|
3303
Pure Cycle
PCYO
$273M
| $59.1K | ﹤0.01% |
5,369
+1,119
| +26% | +$11.1K |
|
3304
Gencor Industries
GENC
$264M
| $58.5K | ﹤0.01% |
3,755
+3,644
| +3,283% | +$52.2K |
|
|
ROSS.WS
3305
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
| $58.4K | ﹤0.01% |
345,000
| – | – |
|
3306
RGC Resources
RGCO
$226M
| $58.2K | ﹤0.01% |
2,905
+2,815
| +3,128% | +$58K |
|
3307
MeiraGTx Holdings
MGTX
$1.17B
| $57.9K | ﹤0.01% |
8,617
+1,427
| +20% | +$9.19K |
|
|
AKTS
3308
DELISTED
Akoustis Technologies Inc
AKTS
| $57.8K | ﹤0.01% |
18,188
+3,664
| +25% | +$11.2K |
|
3309
Lexicon Pharmaceuticals
LXRX
$1.04B
| $57.6K | ﹤0.01% |
25,140
+6,588
| +36% | +$17.5K |
|
3310
Norwood Financial Corp
NWFL
$376M
| $57.1K | ﹤0.01% |
1,935
+1,921
| +13,721% | +$52.6K |
|
3311
XBiotech
XBIT
$71M
| $56.9K | ﹤0.01% |
9,587
+8,114
| +551% | +$36.6K |
|
3312
Sportsman's Warehouse
SPWH
$46.8M
| $56.9K | ﹤0.01% |
9,980
-26,134
| -72% | -$157K |
|
3313
Zai Lab
ZLAB
$2.92B
| $56.7K | ﹤0.01% |
2,045
-155,751
| -99% | -$5.09M |
|
|
TEF
3314
DELISTED
Telefonica
TEF
| $56.5K | ﹤0.01% |
14,008
+2,895
| +26% | +$12.3K |
|
3315
Compañía de Cervecerías Unidas
CCU
$2.16B
| $56.2K | ﹤0.01% |
+3,461
| New | +$55.2K |
|
3316
CALL
Corning
GLW
$137B
| $56.1K | ﹤0.01% |
16
| – | – |
|
3317
Wave Life Sciences
WVE
$1.02B
| $56.1K | ﹤0.01% |
15,400
+14,711
| +2,135% | +$59.4K |
|
3318
Cardlytics
CDLX
$25.1M
| $56K | ﹤0.01% |
886
-1,334
| -60% | -$80.8K |
|
3319
Mistras Group
MG
$584M
| $55.8K | ﹤0.01% |
+7,223
| New | +$53.7K |
|
3320
Scholar Rock
SRRK
$6.46B
| $55.8K | ﹤0.01% |
7,394
+6,488
| +716% | +$49K |
|
3321
Park-Ohio Holdings
PKOH
$718M
| $55.6K | ﹤0.01% |
2,925
+2,914
| +26,491% | +$44.3K |
|
3322
Xenon Pharmaceuticals
XENE
$6.21B
| $55.5K | ﹤0.01% |
1,441
+413
| +40% | +$16.4K |
|
3323
Orrstown Financial Services
ORRF
$855M
| $55.3K | ﹤0.01% |
2,886
-7,280
| -72% | -$135K |
|
3324
HUTCHMED
HCM
$2.11B
| $55.2K | ﹤0.01% |
4,604
-93,799
| -95% | -$1.28M |
|
3325
Lincoln Educational Services
LINC
$955M
| $55.1K | ﹤0.01% |
+8,182
| New | +$51.6K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2023 Portfolio in Review
As of Q2 2023, BNP Paribas Financial Markets held 4,079 positions worth $80B, up 12% from $71.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets's Q2 2023 filing shows 263 new, 1,328 increased, 1,932 reduced and 164 closed positions. Its largest new stake was Direxion NASDAQ-100 Equal Weighted Index ETF: 200,000 shares worth $15.4M. The largest sale was Invesco QQQ Trust, an estimated $643M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- BNP Paribas Financial Markets's largest Q2 2023 buy was Direxion NASDAQ-100 Equal Weighted Index ETF: 200,000 shares worth $15.4M.
- BNP Paribas Financial Markets added most to Alibaba in Q2 2023, an estimated $1.52B increase.
- BNP Paribas Financial Markets's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $643M.
- BNP Paribas Financial Markets fully exited iShares Russell Mid-Cap Growth ETF in Q2 2023, selling an estimated $35.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $80B portfolio in Q2 2023.
- BNP Paribas Financial Markets opened 263 new positions and closed 164 in Q2 2023.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $80B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2023, filed 9 Aug 2023.